Nirma acquires Core Healthcare's IV fluids business

Almost eight years after it landed in debt, thanks to its over ambitious expansion plans, Ahmedabad based Core Healthcare Ltd. (CHL) has finally found a buyer for its intravenous (IV) fluids and medical devices business in Nirma Limited. For the FMCG company this would mean a foray into unchartered territories of pharmaceuticals. The deal for the sale of CHL's assets and liabilities was wrapped up on Thursday evening with a Memorandum of Understanding (MoU) being signed between Nirma and the Asset Reconstruction Company (India) Ltd (ARCIL), CHL founder Sushil Handa said on Thursday. CHL's stock, which had been on the rise in the past few days, touched a 52 week high and closed at Rs 16 on both BSE and NSE.

India's first PET/CT system launched at Tata Memorial Hospital

The first PET/CT system in India - Discovery ST has been installed at the Tata Memorial Hospital (TMH), Mumbai by GE Healthcare, a unit of General Electric Company.

Korean company to set up Asia's largest cord blood bank in India

Korea's leading stem cell research company Histone, in participation with the government of India, is planning to set up Asia's largest cord blood bank in the country. The company, which is is also scouting for a potential private sector partner in India, has been in talks with few local companies including Reliance Life Sciences, it is learnt.

Hindustan Signs mktg pact with BD for auto-disable syringes

Hindustan Latex Ltd (HLL), a Government of India Enterprise, and BD (Becton, Dickinson and Company), a global medical technology company and leader in immunization has signed an agreement to jointly manufacture and market auto-disable syringes in India. The collaboration is expected to help prevent the reuse of syringes through the introduction of auto-disable syringes, education and training of healthcare workers, and the implementation of advocacy programmes with the Government of India.

Win Medicare launches hepatonorm analyzer for detecting liver diseases

Delhi Based win Medicare (P) Ltd has introduced Hepatonorm Analyzer, a novel product to detect Hepatic Encephalopathy - a disease that occur due to acute liver diseases, such as liver cirrhosis in India.

Hindustan Latex looks into clinical services and pharma foray

After making condoms for several decades, Hindustan Latex Ltd has drawn up a major diversification plan which will see the company foraying into hospital products, clinical services and even pharmaceutical sector.

Wockhardt lines up three hospital projects

Wockhardt Hospitals, a unit of the Wockhardt group, is all set to emerge as a national player in the healthcare sector. The company has lined up a couple of projects, which will happen this year and which will help it build its presence across the four geographical regions in the country. Wockhardt Hospitals vice president (operations) Vishal Bali told ET that Wockhardt will start setting up a new hospital in New Delhi and will also build a second hospital in Kolkata.

Nicholas Piramal to rebrand diagnostic labs

Nicholas Piramal's healthcare plans are gaining momentum. The company's diagnostic laboratories business will now foray into smaller metros and semi-urban areas. The company is also planning to rebrand the path labs business. "We will create a mother brand 'Wellspring,' which will be used for all the path labs," Dr. Swati Piramal, director for strategic alliances at Nicholas Piramal, told ET.

IHF lists 50 hospitals as India's medical tourism destinations

The Indian Healthcare Federation (IHF), a grouping of private hospitals, diagnostic centres, medical equipment manufacturers and pharmaceutical companies, is to hand over a list of 50 hospitals, spread across 15 cities, to the Central Government as potential centres for medical tourism. The details are meant to be publicized internationally by the government to boost health tourism in the country.

Medtronic, Novo team to enhance diabetes management

The Diabetes business unit of Medtronic, Inc, the world leader in insulin pump therapy, and Novo Nordisk have entered into an agreement to develop the first prefilled cartridges designed for use with Paradigm external insulin pumps. The two companies also agreed to conduct clinical studies and expand medical education highlighting the benefits of maintaining good blood glucose (sugar) control in people with diabetes who use U-100 NovoLog (insulin aspart [rDNA origin] injection) and Paradigm pump therapy.